Delayed elimination of enoxaparin in patients wit... [Thromb Res. 1991] - PubMed

Save items

loading

Related citations in PubMed

Pharmacokinetic of a very low molecular weight heparin in chronic renal failure. [Thromb Res. 1991]
Pharmacokinetic of a very low molecular weight heparin in chronic renal failure.
Hory B, Claudet MH, Magnette J, Bechtel P, Bayrou B. Thromb Res. 1991 Aug 1; 63(3):311-7.
Pharmacokinetics of a low molecular weight heparin (Fraxiparine) in various stages of chronic renal failure. [Nephron. 1991]
Pharmacokinetics of a low molecular weight heparin (Fraxiparine) in various stages of chronic renal failure.
Goudable C, Saivin S, Houin G, Sie P, Boneu B, Tonthat H, Suc JM. Nephron. 1991; 59(4):543-5.
Review Pharmacokinetics of heparin and low molecular weight heparin. [Baillieres Clin Haematol. 1990]
Review Pharmacokinetics of heparin and low molecular weight heparin.
Boneu B, Caranobe C, Sie P. Baillieres Clin Haematol. 1990 Jul; 3(3):531-44.
[Enoxaparin in the prevention of thrombosis of extracorporeal circulation during dialysis of patients with chronic renal failure]. [Rev Med Interne. 1988]
[Enoxaparin in the prevention of thrombosis of extracorporeal circulation during dialysis of patients with chronic renal failure].
Pouzol P, Dechelette E, Jurkovitz C, Kuentz F, Polack B. Rev Med Interne. 1988 May-Jun; 9(3):321-6.
Review Low molecular weight heparin and haemodialysis: neutralization by protaminchloride. [Blood Coagul Fibrinolysis. 1993]
Review Low molecular weight heparin and haemodialysis: neutralization by protaminchloride.
Andrassy K. Blood Coagul Fibrinolysis. 1993 Dec; 4 Suppl 1:S39-43.

See reviews... See all...

Cited by 3 PubMed Central articles

Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants. [Thromb J. 2011]
Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants.
Perka C. Thromb J. 2011 Nov 16; 9:17. Epub 2011 Nov 16.
Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. [Crit Care. 2006]
Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study.
Rommers MK, Van der Lely N, Egberts TC, van den Bemt PM. Crit Care. 2006; 10(3):R93. Epub 2006 Jun 21.
Dosing strategy for enoxaparin in patients with renal impairment presenting with acute coronary syndromes. [Br J Clin Pharmacol. 2005]
Dosing strategy for enoxaparin in patients with renal impairment presenting with acute coronary syndromes.
Green B, Greenwood M, Saltissi D, Westhuyzen J, Kluver L, Rowell J, Atherton J. Br J Clin Pharmacol. 2005 Mar; 59(3):281-90.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Delayed elimination of enoxaparin in patients with chronic renal insufficiency.
Delayed elimination of enoxaparin in patients with chronic renal insufficiency.
Thromb Res. 1991 Aug 1 ;63(3):385-90.

PubMed
Prevalence of overweight and obesity in the United States, 1999-2004.
Prevalence of overweight and obesity in the United States, 1999-2004.
JAMA. 2006 Apr 5 ;295(13):1549-55.

PubMed
Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in ...
Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.
J Pharmacol Exp Ther. 1991 Nov ;259(2):712-8.

PubMed
BID as a double agent in cell life and death.
BID as a double agent in cell life and death.
Cell Cycle. 2006 Mar ;5(6):582-4. Epub 2006 Mar 15 .

PubMed
Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid...
Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines.
J Clin Invest. 1991 Nov ;88(5):1656-62.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Delayed elimination of enoxaparin in patients with chronic renal insufficiency.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Medical

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information